Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Recruiting

I'm Interested

Trial ID: NCT06173401

Purpose

The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor control compared to single-fraction SRS. Patients will be randomized to treatment with spine SRS using either 22 Gy in 1 fraction or 28 Gy in 2 fractions.

Official Title

A Randomized Phase III TriaL Comparing SingLe- Versus Multi-Fraction Spine STereotActic Radiosurgery for Patients With Spinal Metastases (ALL-STAR)

Stanford Investigator(s)

Erqi Pollom
Erqi Pollom

Associate Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery

Melanie Hayden Gephart
Melanie Hayden Gephart

Professor of Neurosurgery and, by courtesy, of Neurology

Eligibility


Inclusion Criteria:

   - Histologically, cytologically, or radiographically confirmed diagnosis of metastatic
   cancer Age ≥ 18 years

   - Patients who have cervical, thoracic, or lumbar spine metastasis that need treatment.

   - Patients will have 1 to 3 separate spinal sites that require treatment.

   - Each spinal site to be treated on trial will span 1-2 contiguous vertebral levels

   - ECOG 0-2

   - Negative serum or urine pregnancy test within 14 days prior to enrollment for women of
   childbearing potential or who are not postmenopausal

   - Women of childbearing potential and male participants who are sexually active must
   agree to use a medically effective means of birth control

   - Ability to understand and the willingness to sign (personally or by a legal authorized
   representative) the written IRB approved informed consent document

Exclusion Criteria:

   - Prior or planned radiation off study within or overlapping with study treatment site

   - Inability to have either an MRI or a CT scan. Patients with pacemaker will be allowed
   to undergo CT instead of MRI

   - Pediatric patients (age <18 years old), pregnant women, and nursing patients will be
   excluded

   - Histology's of myeloma or lymphoma

   - Patients with strength 1-3 (of 5), bladder incontinence, bowel incontinence, and/or
   bladder retention that is associated with spinal site to be treated

   - Prior surgery to spinal site intended to be treated with protocol SRS

   - Excluded those with SINS 13-18

Intervention(s):

radiation: Single-fraction spine SRS

radiation: Multi-fraction spine SRS

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Aniket Pratapneni
650-723-3110

New Trial Alerts